WG12 - Task Groups
Staff dosimetry (SG1)
-
Task 1.2 - Dose constraints in interventional cardiology
Task leader: joanna [dot] domienik [at] imp [dot] lodz [dot] pl (Joanna Domienik-Andrzejewska) (NIOM, Poland)
Aim of the task: Verifying if there is a harmonised approach for setting dose constraints available in the literature. Setting the dose constraints for the occupational exposure in IC/IR from the dose databases. Preparing guidlines presenting the methodology followed.
-
Task 1.3 - Practical Worksheets: (joint task SG1/SG2)
Task leader: isabelle [dot] clairand [at] irsn [dot] fr (Isabelle Clairand) (IRSN, France)
Aim of the task: Establishing a series of EURADOS practical synthetic worksheets (infographics), using material coming from EURADOS publications (articles, reports…) and general information on dosimetry.
-
Task 1.4 - AI in Interventional Procedures
Task leader: jeremie [dot] dabin [at] sckcen [dot] be (Jérémie Dabin) (SCK CEN, Belgium)
Aim of the task: Investigateing artificial intelligence algorithms for estimating staff doses during interventional procedures. Different inputs for the AI model will be considered to get valuable insights on the generation and use of AI in medical staff dosimetry.
-
Task 1.8 - Extremity doses in nuclear medicine focussed on the new radionuclides
Task leader: kollaard [at] nrg [dot] eu (Robert Kollaard) (NRG, The Netherlands)
Aim of the task: The purpose of this obtain an overview of the exposure of the extremities due to preparation, dispensing and administration of radiopharmaceuticals in nuclear medicine. The task is divided in a review and two questionnaires to gain insight in the current status of on one hand and is on the other hand investigating the exposure of the fingers due to the use of new radionuclides such as 68Ga and 177Lu.
-
Task 1.9 - Occupational exposure during the management, preparation and administration of "new" radiopharmaceuticals
Task leader: paolo [dot] ferrari [at] enea [dot] it (Paolo Ferrari) (ENEA, Italy)
Aim of the task: New radiopharmaceuticals for nuclear medicine theranostic practices, that combines therapy and diagnostic applications, are getting available in the market and their number is expected to increase in the future years. The main purpose of this task is investigating the exposure of the personnel and the public associated to their preparation and their administration to the patient.
This is a joint task with WG6, WG7 and WG12.
Patient dosimetry (SG2)
-
Task 2.2 - Personalized dose in radiotherapy
Task leader: teemu [dot] siiskonen [at] stuk [dot] fi (Teemu Siiskonen) (STUK, Finland)
Aim of the task: Methods to calculate patient organ and effective doses in real patient anatomy are developed in this task. More specific tasks include the characterization of radiotherapy imaging devices, surveys of imaging frequencies and protocols (together with IAEA and ICRP), assessing the patient exposures using experimental and computational methods and producing good practice guides and recommendations for radiotherapy imaging (together with EFOMP).
This is a joint work between WG6, WG9 and WG12 and EFOMP.
-
Task 2.4 - Dosimetry in pregnancy
Task leader: dariofaj [at] mefos [dot] hr (Dario Faj) (Medical Faculty Osijek, Croatia)
Aim of the task: To review, validate and compare different approaches for dosimetry in pregnancy related to medical exposure for all ionizing radiation modalities used in imaging (diagnostic radiology and nuclear medicine). The task started with a literature review and a questionnaire to gain insight in the radiation protection considerations and dosimetry approaches used. It will be followed by assessing the pregnant patient exposures using experimental and computational methods in different clinical settings.
-
Task 2.5 - Organ doses in interventional radiology
Task leader: nicolas [dot] arbor [at] iphc [dot] cnrs [dot] fr (Nicolas Arbor )(University of Strasbourg, France)
Aim of the task: This task is interested in the issue of the accuracy and reliability of organ dose estimate in interventional radiology. The main purpose is to characterize the variability of measurements and calculations depending on the different parameters that can affect the dose reconstruction (DICOM RDSR data, manufacturers, dosimetry tools, …).